Abstract
Corrigendum] LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL‑6 and TNF‑α.
Highlights
Following the publication of the above paper, the authors realized that, in their follow‐up experiments, the STAT3 and p65 antibodies they used had already expired prior to the results being published
The revised figures are presented on the two pages (Figs 1-4). Repeating these particular experiments has resulted in the following changes being necessary to the text of the published paper: i) The fourth sentence in the Abstract, on p. 2389, should read as follows: “The results revealed that the expression of LYPD8 was significantly reduced in the CRC tissue compared with that in precancerous tissue and normal tissue, in stage IV tissue.” (‘III’ has been changed to ‘IV’)
SW480 (ATCC® CCL‐228TM, organism, human; tissue, colon; disease, colorectal adenocarcinoma), SW620 (ATCC® CCL‐227TM, organism, human; tissue, colon; derived from metastatic site, lymph node; disease, colorectal adenocarcinoma), HCT116 (ATCC® CCL‐247TM, organism, human; tissue, colon; disease, colorectal carcinoma) and RKO (ATCC® CRL‐2577TM, organism, human; tissue, colon; disease, carcinoma) cells were purchased from the American Type Culture Collection (Manassas, VA, USA)
Summary
Following the publication of the above paper, the authors realized that, in their follow‐up experiments, the STAT3 and p65 antibodies they used had already expired prior to the results being published. 2389, should read as follows: “The results revealed that the expression of LYPD8 was significantly reduced in the CRC tissue compared with that in precancerous tissue and normal tissue, in stage IV tissue.” (‘III’ has been changed to ‘IV’).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
